Filing Details
- Accession Number:
- 0001127602-15-021322
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-24 17:56:14
- Reporting Period:
- 2015-06-24
- Filing Date:
- 2015-06-24
- Accepted Time:
- 2015-06-24 17:56:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1008891 | Blaine A Bowman | 5200 Illumina Way San Diego CA 92122 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-06-24 | 3,000 | $39.14 | 16,615 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-06-24 | 300 | $219.30 | 16,315 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-06-24 | 1,390 | $220.86 | 14,925 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-06-24 | 491 | $221.99 | 14,434 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-06-24 | 819 | $222.83 | 13,615 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2015-06-24 | 3,000 | $0.00 | 3,000 | $39.14 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
3,000 | 2009-05-07 | 2018-05-16 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 670 | Indirect | By Partnership |
Common Stock | 198 | Indirect | By Trust |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 300 shares sold ranging from $219.16 to $219.38 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 1,390 shares sold ranging from $220.34 to $221.20 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 491 shares sold ranging from $221.39 to $222.38 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 819 shares sold ranging from $222.45 to $223.00 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.